How about:

Paroxetine Hydrochloride Hemihydrate

--------------------------------------------------
Note added at 2004-04-20 18:02:33 (GMT)
--------------------------------------------------

E.g. \"After a three week trial, where Apotex Corp., Apotex, Inc. and TorPharm, Inc. (“Apotex”) were represented by the law firm of Lord, Bissell & Brook, the Honorable Richard A. Posner, sitting by designation in the United States District Court for the Northern District of Illinois in Chicago, ruled that the patent that GSK was heavily relying upon to prevent generic competition, U.S. Patent No. 4,721,723 (“’723 patent”) for crystalline paroxetine hydrochloride hemihydrate, was not infringed by the paroxetine hydrochloride anhydrous product that Apotex proposes to market pursuant to its ANDA (Abbreviated New Drug Application). \"

ref. http://www.apotex.com/PressReleases/20030304-01.asp?flash=Ye...

--------------------------------------------------
Note added at 2004-04-20 18:29:41 (GMT)
--------------------------------------------------

The strict timing requirements for listing a patent on the Register are to ensure that generics are not unfairly impeded from accessing the market. Glaxo markets paroxetine hydrochloride hemihydrate tablets for which an original NOC was filed, long before several patents for the same drug issued.

ref. http://www.bereskinparr.com/publications/rcd/pub_rcd_dec_200...

--------------------------------------------------
Note added at 2004-04-20 18:50:37 (GMT)
--------------------------------------------------

(It\'s an antidepressant)

\"GlaxoSmithKline PLC (GSK) holds a patent (4,721,723) on crystalline paroxetine hydrochloride hemihydrate, which GSK sells as the antidepressant drug Paxil. \"

ref. http://subscript.bna.com/SAMPLES/ptc.nsf/0/47fda8e13a7fbee78...